₹2,700 cancer medicine sold for ₹27,000: Supreme Court flags "broad daylight dacoity" of patients
Cite this
Citations are auto-generated; verify before publishing. The news classification is PolicyDhara's, not the source's.
News coverage — journalism about policy, not a policy document. Useful as timely context; the underlying instrument is linked where known.
Summary
The Supreme Court on Tuesday took serious exception to the absence of price-control mechanisms for life-saving medicines as it flagged huge differences between the Price to Retailer (PTR) and Maximum Retail Price (MRP) of cancer-curing drugs [Kishan Chand Jain v. Union of India]. A Bench of Justices Vikram Nath and Sandeep Mehta said the difference in prices is nothing short of daylight robbery being committed on vulnerable patients by drug manufacturers and retailers. "There are essential medic